| Literature DB >> 25928293 |
Atif Sarwar1, Haliza Katas1, Siti Noradila Samsudin1, Noraziah Mohamad Zin2.
Abstract
Recently, the attention of researchers has been drawn toward the synthesis ofEntities:
Mesh:
Substances:
Year: 2015 PMID: 25928293 PMCID: PMC4415788 DOI: 10.1371/journal.pone.0123084
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Synthetic scheme of chitosan derivatives.
Synthetic scheme of chitosan azide functional derivatives.(i) phthalic anhydride, DMF 5%(v/v), 8h, N2 atmosphere,120°C, (ii) THF,CDI, 5h, N2 atmosphere, 40°C, propargylamine, THF,24h, 25°C, (iii) sodium ascorbate, copper (II) acetate, (1-azidoadamantane / azidobenzene/ 1-azidomethyl-2-methyl benzene / azidomethyl phenyl sulphide / 2-azidomethyl-1-boc pyrolidine), tertbutanol/ water, 24h, 25°C, (iv) NH2NH2.H2O,water, 18h, 100°C.
Fig 2Fourier transform infrared (FTIR) spectra.
Figure showing fouriertransforminfrared (FTIR) spectra of (a) Chitosan, (b) N-phthaloyl-chitosan, (c) N-phthaloyl-chitosan O-prop-2-ynyl carbamate, (d) derivative 1, (e) derivative 2, (f) derivative 3, (g) derivative 4, and (h) derivative 5.
Fig 31H Nuclear magnetic resonance (1H NMR) spectra.
Figure showing 1Hnuclear magnetic resonance (1HNMR) spectra of (a) derivative 1, (b) derivative 2, (c) derivative 3, (d) derivative 4, and (e) derivative 5.
Elemental analysis of chitosan and derivatives.
| C | H | N | S | |
|---|---|---|---|---|
| Chitosan | 40.04 | 7.11 | 7.51 | —- |
| Derivative 1 | 54.55 | 6.88 | 15.76 | —- |
| Derivative 2 | 50.39 | 6.02 | 17.18 | —- |
| Derivative 3 | 52.72 | 5.82 | 16.83 | —- |
| Derivative 4 | 48.41 | 5.25 | 16.09 | 7.14 |
| Derivative 5 | 48.98 | 6.77 | 17.13 | —- |
Fig 4TGA of chitosan and derivaties.
Figure showing the thermograms of chitosan and derivativesby using thermogravimetric analysis (TGA).
Fig 5DSC of chitosan and derivatives.
(A) First DSC curve of chitosan and derivatives obtained at a heating rate of 10 °C /min and (B) Second DSC curve of dry chitosan and derivatives obtained at a heating rate of 10 °C /min/.
Fig 6SEM images of chitosan and derivatives.
Figure showing scanning electron micrographs (CS) chitosan(a) derivative 1, (b) derivative 2, (c) derivative 3, (d) derivative 4, and (e) derivative 5.
Particle size, polydispersity, zeta potential, antibacterial and antifungal activities of CSNP3, CSNP4 and CSNP5.(n = 3).
| CSNP | Particle size | Polydispersity index | Zeta potential | MIC / MBC (μg/mL) | MIC / MFC (μg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (nm) | (μ2/Γ 2) | (mV) | Gram positive bacteria | Gram negative bacteria | Fungi | |||||||
|
|
|
|
|
|
|
|
|
| ||||
|
| 181.03 ± 12.73 | 0.49 ± 0.02 | 22.14 ± 0.89 | 3.13/3.13 | 1.56/3.13 | 1.56/3.13 | 6.25/6.25 | 6.25/25 | 3.13/3.13 | 375/1500 | 94/750 | 375/1500 |
|
| 222.04 ± 19.01 | 0.33 ± 0.04 | 24.12 ± 1.41 | 3.13/3.13 | 3.13/6.25 | 3.13/6.25 | 6.25/6.25 | 6.25/12.5 | 6.25/12.5 | 188/375 | 94/750 | 375/1500 |
|
| 236.50 ± 14.32 | 0.22 ± 0.02 | 22.40 ± 6.25 | 12.5/25 | 12.5/12.5 | 12.5/12.5 | 25.0/50.0 | 25.0/25.0 | 12.5/25.0 | 750/3000 | 188/1500 | 750/3000 |
Fig 7TEM images of chitosan derivatives nanoparticles.
Figure showing transmission electron micrographs(a1, a2), (b1, b2), and (c1, c2) represents CSNP3, CSNP4, and CSNP5 respectively.
Fig 8TEM images of bacteria. Figure showing morphology of bacteria.
(a) untreatedE. coli (b) untreated S. aureus. (a1-a3) showE.coli and (b1-b3) show S. aureus treated with CSNP3, CSNP4, andCSNP5.
Antibacterial and antifungal activity of chitosan and derivatives.
(n = 3).
| Compounds | MIC / MBC (μg/mL) | MIC / MFC (μg/mL) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gram positive bacteria | Gram negative bacteria | Fungi | ||||||||
|
|
|
|
|
|
|
|
|
| ||
|
| 62.5 / 250 | 250 / 500 | 125 / 250 | 125 / 250 | 250 / 500 | 125 / 500 | 1500 /—- | 375 / 1500 | 1500 /—- | |
|
| 62.5 / 125 | 125 / 250 | 62.5 / 250 | 125 / 250 | 125 / 500 | 125 / 250 | 1500 /—- | 375 / 1500 | 750 / 3000 | |
|
| 31.3 / 62.5 | 62.5 / 250 | 31.3 / 62.5 | 31.3 / 62.5 | 125 / 250 | 31.3 / 125 | 1500 /—- | 188 / 1500 | 750 / 3000 | |
|
| 31.3 / 62.5 | 62.5 / 250 | 31.3 / 62.5 | 31.3 / 62.5 | 125 / 250 | 31.3 / 125 | 750 /—- | 188 / 1500 | 750 / 3000 | |
|
| 62.5 / 125 | 62.5 / 250 | 62.5 / 250 | 125 / 250 | 125 / 250 | 125 / 500 | 1500 /—- | 375 / 3000 | 1500 / 3000 | |
|
| 125 / 250 | 500 /—- | 125 / 500 | 250 / 500 | 500 /—- | 500 /—- | 3000 /—- | 3000 /—- | 3000 /—- | |
Fig 9Cell viability of chitosan and derivatives.
Figure showing the cell viability effects of chitosan and derivatives on (A) Chinese hamster lung fibroblast cell line V79 and (B) Human hepatic cell line WRL68. Data was presented asmean ± SD (n = 3).
Hemolytic activity of chitosan and derivatives.
(n = 3).
| SI = HC50 / MIC(μg/ml) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Compounds | HC50(μg/ml) | Gram positive bacteria | Gram negative bacteria | Fungi | ||||||
|
|
|
|
|
|
|
|
|
| ||
|
| 4000 | 128 | 32 | 64 | 64 | 32 | 64 | 5.3 | 21.3 | 5.3 |
|
| 8000 | 128 | 64 | 128 | 64 | 64 | 64 | 5.3 | 21.3 | 10.7 |
|
| 8000 | 255.6 | 128 | 255.6 | 255.6 | 64 | 255.6 | 5.3 | 42.6 | 10.7 |
|
| 4000 | 127.8 | 64 | 127.8 | 127.8 | 32 | 127.8 | 5.3 | 21.3 | 5.3 |
|
| 4000 | 64 | 64 | 64 | 32 | 32 | 32 | 2.7 | 10.7 | 2.7 |
|
| 16000 | 128 | 32 | 128 | 64 | 32 | 32 | 5.3 | 5.3 | 5.3 |